Literature DB >> 28683298

Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.

Rigel J Kishton1, Madhusudhanan Sukumar2, Nicholas P Restifo3.   

Abstract

Cancer immunotherapy is an increasingly successful strategy for the treatment of patients who have advanced or conventional therapy-resistant cancers. T cells are key mediators of tumor destruction and their specificity for tumor-expressed antigens is of paramount importance, but other T cell-intrinsic qualities, such as durability, longevity, and functionality also play important roles in determining the efficacy of immunotherapy. The cellular energetic pathways that are utilized by T cells play a key role in regulating each of these qualities. Metabolic activity, which both regulates and is regulated by cellular signaling pathways and epigenetics, also profoundly influences the trajectories of T cell differentiation and fate. In this Review, we discuss how cell metabolism influences T cell anti-tumor activity, the metabolic qualities of highly-functional T cells, and strategies to modulate metabolism for improving the immune response to tumors. Published by Elsevier Inc.

Entities:  

Keywords:  T cell metabolism; aging; cancer; checkpoint inhibitor; differentiation; epigenetics; immunotherapy; longevity; memory; tumor

Mesh:

Year:  2017        PMID: 28683298      PMCID: PMC5543711          DOI: 10.1016/j.cmet.2017.06.016

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  174 in total

1.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

2.  Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Rahul Roychoudhuri; David Clever; Alena Gros; Robert L Eil; Eric Tran; Ken-Ichi Hanada; Zhiya Yu; Douglas C Palmer; Sid P Kerkar; Ryan D Michalek; Trevor Upham; Anthony Leonardi; Nicolas Acquavella; Ena Wang; Francesco M Marincola; Luca Gattinoni; Pawel Muranski; Mark S Sundrud; Christopher A Klebanoff; Steven A Rosenberg; Douglas T Fearon; Nicholas P Restifo
Journal:  Cancer Res       Date:  2014-11-28       Impact factor: 12.701

3.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation.

Authors:  Ruoning Wang; Christopher P Dillon; Lewis Zhichang Shi; Sandra Milasta; Robert Carter; David Finkelstein; Laura L McCormick; Patrick Fitzgerald; Hongbo Chi; Joshua Munger; Douglas R Green
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

4.  Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.

Authors:  James N Kochenderfer; Wyndham H Wilson; John E Janik; Mark E Dudley; Maryalice Stetler-Stevenson; Steven A Feldman; Irina Maric; Mark Raffeld; Debbie-Ann N Nathan; Brock J Lanier; Richard A Morgan; Steven A Rosenberg
Journal:  Blood       Date:  2010-07-28       Impact factor: 22.113

5.  Prospects for gene-engineered T cell immunotherapy for solid cancers.

Authors:  Christopher A Klebanoff; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Med       Date:  2016-01       Impact factor: 53.440

Review 6.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

7.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

Review 8.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

9.  Activated lymphocytes as a metabolic model for carcinogenesis.

Authors:  Andrew N Macintyre; Jeffrey C Rathmell
Journal:  Cancer Metab       Date:  2013-01-23

10.  Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape.

Authors:  Joseph G Crompton; Manikandan Narayanan; Suresh Cuddapah; Rahul Roychoudhuri; Yun Ji; Wenjing Yang; Shashank J Patel; Madhusudhanan Sukumar; Douglas C Palmer; Weiqun Peng; Ena Wang; Francesco M Marincola; Christopher A Klebanoff; Keji Zhao; John S Tsang; Luca Gattinoni; Nicholas P Restifo
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

View more
  133 in total

1.  Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death.

Authors:  Tsadik Habtetsion; Zhi-Chun Ding; Wenhu Pi; Tao Li; Chunwan Lu; Tingting Chen; Caixia Xi; Helena Spartz; Kebin Liu; Zhonglin Hao; Nahid Mivechi; Yuqing Huo; Bruce R Blazar; David H Munn; Gang Zhou
Journal:  Cell Metab       Date:  2018-06-07       Impact factor: 27.287

2.  T cell stemness and dysfunction in tumors are triggered by a common mechanism.

Authors:  Suman Kumar Vodnala; Robert Eil; Rigel J Kishton; Madhusudhanan Sukumar; Tori N Yamamoto; Ngoc-Han Ha; Ping-Hsien Lee; MinHwa Shin; Shashank J Patel; Zhiya Yu; Douglas C Palmer; Michael J Kruhlak; Xiaojing Liu; Jason W Locasale; Jing Huang; Rahul Roychoudhuri; Toren Finkel; Christopher A Klebanoff; Nicholas P Restifo
Journal:  Science       Date:  2019-03-29       Impact factor: 47.728

3.  Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells.

Authors:  Paramita Chakraborty; Shilpak Chatterjee; Pravin Kesarwani; Krishnamurthy Thyagarajan; Supinya Iamsawat; Annika Dalheim; Hung Nguyen; Shanmugam P Selvam; Patrick Nasarre; Gina Scurti; Gary Hardiman; Nilanjana Maulik; Lauren Ball; Vamsi Gangaraju; Mark P Rubinstein; Nancy Klauber-DeMore; Elizabeth G Hill; Besim Ogretmen; Xue-Zhong Yu; Michael I Nishimura; Shikhar Mehrotra
Journal:  J Biol Chem       Date:  2019-04-10       Impact factor: 5.157

4.  Single-Cell Signature Explorer for comprehensive visualization of single cell signatures across scRNA-seq datasets.

Authors:  Frédéric Pont; Marie Tosolini; Jean J Fournié
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

Review 5.  Metabolism and immunity in breast cancer.

Authors:  Deyu Zhang; Xiaojie Xu; Qinong Ye
Journal:  Front Med       Date:  2020-10-19       Impact factor: 4.592

6.  Caloric restriction promotes the stemness and antitumor activity of T lymphocytes.

Authors:  Federico Pietrocola; Guido Kroemer
Journal:  Oncoimmunology       Date:  2019-05-16       Impact factor: 8.110

Review 7.  Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy.

Authors:  Adam J Wolpaw; Chi V Dang
Journal:  Trends Cell Biol       Date:  2017-12-08       Impact factor: 20.808

8.  Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade.

Authors:  Koji Nagaoka; Akihiro Hosoi; Tamaki Iino; Yasuyuki Morishita; Hirokazu Matsushita; Kazuhiro Kakimi
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

9.  Therapeutic Time-restricted Feeding Reduces Renal Tumor Bioluminescence in Mice but Fails to Improve Anti-CTLA-4 Efficacy.

Authors:  William J Turbitt; Rachael M Orlandella; Justin T Gibson; Courtney M Peterson; Lyse A Norian
Journal:  Anticancer Res       Date:  2020-10       Impact factor: 2.480

Review 10.  Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes.

Authors:  William J Turbitt; Claire Buchta Rosean; K Scott Weber; Lyse A Norian
Journal:  Immunol Rev       Date:  2020-03-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.